09:55 AM EDT, 05/07/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Wednesday its US operations will no longer take part in a global initiative on gender representation because of "evolving legal requirements."

The company said that worldwide, it continues to work to achieve representation of at least 45% for each gender by the end of this year.

"We remain committed to non-discrimination and innovation through diverse perspectives, always in compliance with local regulations," the Danish drugmaker said in its Q1 earnings release.

Price: 68.68, Change: +2.39, Percent Change: +3.61